Does BROMAZEPAM Cause Incorrect product administration duration? 62 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Incorrect product administration duration have been filed in association with BROMAZEPAM. This represents 1.0% of all adverse event reports for BROMAZEPAM.
62
Reports of Incorrect product administration duration with BROMAZEPAM
1.0%
of all BROMAZEPAM reports
1
Deaths
27
Hospitalizations
How Dangerous Is Incorrect product administration duration From BROMAZEPAM?
Of the 62 reports, 1 (1.6%) resulted in death, 27 (43.5%) required hospitalization, and 19 (30.6%) were considered life-threatening.
Is Incorrect product administration duration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROMAZEPAM. However, 62 reports have been filed with the FAERS database.
What Other Side Effects Does BROMAZEPAM Cause?
Drug abuse (964)
Toxicity to various agents (914)
Coma (790)
Somnolence (641)
Intentional overdose (467)
Poisoning deliberate (419)
Fall (385)
Hypotension (375)
Drug use disorder (351)
Suicide attempt (345)
What Other Drugs Cause Incorrect product administration duration?
ETONOGESTREL (3,974)
POLYETHYLENE GLYCOL 3350 (2,129)
NIRMATRELVIR\RITONAVIR (744)
DOCOSANOL (634)
LANSOPRAZOLE (564)
LOPERAMIDE (543)
NAPROXEN (499)
INSULIN LISPRO (479)
DICLOFENAC (362)
OMEPRAZOLE (302)
Which BROMAZEPAM Alternatives Have Lower Incorrect product administration duration Risk?
BROMAZEPAM vs BROMFENAC
BROMAZEPAM vs BROMHEXINE
BROMAZEPAM vs BROMOCRIPTINE
BROMAZEPAM vs BROTIZOLAM
BROMAZEPAM vs BUCILLAMINE